Testimonials:
Don’t take it from us, read about Conure’s lineage of success directly from other entrepreneurs
Ron Cohen
Founder, President, and CEO, Acorda Therapeutics
"In May 2003, Easton led a $55.3 million financing for Acorda Therapeutics, one of the top three private biotechnology financings to date in 2003. Easton's ability to lead such a significant round, particularly in a challenging financial environment, is a testament to its capabilities and excellence. Acorda's management and Board were thoroughly impressed by the acumen and performance of the people at Easton. They comprise a rare mix of expertise in finance, life sciences, business development and value creation, together with meticulous attention to detail and passionate commitment. We are especially pleased that John Friedman has joined our Board of Directors, where we expect his insights to contribute substantially to Acorda's future successes."
David Musket
General Partner, ProMed Asset Management LLC
"Easton Hunt brings a diversity of business experience to the investment process. Their insights into business models and strategic plans have been extremely helpful to both CEOs and co-investors. This constant revalidation of business practices has proven to be a very valuable exercise and distinguishes Easton as a very active Board member. A year ago, I might have said that Easton Hunt may be the best medical technology venture firm that no one has heard of. That's no longer the case. Everyone has heard of them."